Bicara Therapeutics Inc. Common Stock (BCAX) — Defensive Interval Ratio
Bicara Therapeutics Inc. Common Stock (BCAX) has a Defensive Interval Ratio of 3364 days as of June 2026. Defensive assets of $400.66 Million (cash $-, short-term investments $400.66 Million, receivables $-) cover 3364 days of daily cash needs of $119.11K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Bicara Therapeutics Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Bicara Therapeutics Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 3364 days, meaning defensive assets of $400.66 Million can fund 3364 days of operations without new revenue. For the complete balance sheet picture, see Bicara Therapeutics Inc. Common Stock (BCAX) total assets.
Annual Defensive Interval Ratio for Bicara Therapeutics Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Bicara Therapeutics Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Bicara Therapeutics Inc. Common Stock (BCAX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4011 days | $318.12 Million | $79.31K/day | $- | $318.12 Million | ▲ +4011 days |
| 2024 | 0 days | $0.00 | $49.29K/day | $- | $0.00 | — |